Rethinking QRS duration as an indication for CRT

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Stavrakis et al. are to be congratulated on a meticulous analysis of major CRT trials and give us an elegant and simple parameter for making the difficult judgment on who is most likely to benefit from CRT. This decision impacts not only individual patient likelihood of benefit but has major implications on societal costs for this important but expensive therapy.25 What is most remarkable from their findings is that despite the quagmire of various confounding variables and the vagaries of electromechanical coupling, their analysis may cause us to RethinQ how we choose patients for CRT.

Original languageEnglish (US)
Pages (from-to)169-171
Number of pages3
JournalJournal of cardiovascular electrophysiology
Issue number2
StatePublished - Feb 2012

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)


Dive into the research topics of 'Rethinking QRS duration as an indication for CRT'. Together they form a unique fingerprint.

Cite this